
Hunan Jiudian Pharmaceutical Co., Ltd.
SZSE:300705.SZ
24.47 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| 512.377 | 368.261 | 269.7 | 204.246 | 82.26 | 55.066 | 71.985 | 68.573 | 54.527 | 44.643 | 37.787 | 36.256 |
Depreciation & Amortization
| 94.969 | 71.476 | 59.696 | 53.58 | 48.238 | 37.354 | 22.436 | 15.619 | 12.8 | 10.977 | 9.829 | 7.045 |
Deferred Income Tax
| 0 | -24.164 | -8.473 | -11.342 | -2.989 | -8.874 | 2.011 | -7.153 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 21.412 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 111.804 | -61.952 | -126.066 | -103.146 | 5.259 | -11.001 | -28.697 | -5.572 | -12.852 | -23.446 | -19.46 | -15.557 |
Accounts Receivables
| 137.011 | -125.789 | -224.111 | -115.632 | -44.431 | 3.114 | -41.538 | -34.354 | -13.037 | -22.814 | -15.719 | -9.323 |
Inventory
| -91.251 | -24.062 | -32.101 | -76.925 | -23.985 | -29.07 | -13.823 | -18.49 | -13.512 | -7.485 | -4.148 | -11.757 |
Accounts Payables
| 0 | 112.063 | 138.619 | 100.752 | 76.664 | 23.829 | 24.652 | 54.424 | 0 | 0 | 0 | 0 |
Other Working Capital
| 66.044 | -24.164 | -8.473 | -11.342 | -2.989 | -8.874 | -14.874 | 12.918 | 0.66 | -15.961 | -15.312 | -3.8 |
Other Non Cash Items
| 27.214 | 77.564 | 65.658 | 36.191 | 14.238 | 9.322 | 2.509 | 1.8 | 0.707 | 0.021 | 1.951 | 2.948 |
Operating Cash Flow
| 746.365 | 431.185 | 268.989 | 190.872 | 149.995 | 90.741 | 68.234 | 80.419 | 55.183 | 32.195 | 30.108 | 30.693 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -397.868 | -426.818 | -413.381 | -125.928 | -78.353 | -181.988 | -257.261 | -97.76 | -31.412 | -29.592 | -26.495 | -45.568 |
Acquisitions Net
| 0 | 0 | 0.125 | -6.429 | 0.047 | 3.059 | 257.399 | 0 | 0 | -0.76 | 0 | -5.8 |
Purchases Of Investments
| -788.124 | -180 | -360 | -380 | 0 | 0 | -150 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 534.274 | 180 | 341.901 | 282.536 | 0 | 0 | 150.854 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0.116 | 2.243 | 0 | 0.265 | 0 | 0 | -257.261 | -97.76 | -31.412 | 0.195 | 0.412 | 8.858 |
Investing Cash Flow
| -651.602 | -424.575 | -431.355 | -229.556 | -78.306 | -178.929 | -256.269 | -97.76 | -31.412 | -30.156 | -26.083 | -42.51 |
Financing Activities: | ||||||||||||
Debt Repayment
| 20.2 | -206.173 | 190.322 | 35.953 | -51.734 | 60.468 | 75.689 | -16 | 0 | 5 | -15 | 10 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -115.711 | -94.622 | -61.253 | -10.091 | -8.448 | -11.03 | -15.534 | -0.677 | -13.649 | -0.923 | -4.988 | -2.065 |
Other Financing Activities
| 19.058 | 374.346 | -8.049 | 262.621 | -0 | 0 | 0 | 259.644 | 26.712 | 0 | 0.833 | 48.147 |
Financing Cash Flow
| -76.454 | 73.551 | 121.019 | 283.562 | -65.503 | 44.976 | 60.156 | 242.967 | 13.063 | 4.077 | -19.155 | 56.082 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0.015 | -0.115 |
Net Change In Cash
| 18.309 | 80.161 | -41.347 | 244.878 | 6.185 | -43.212 | -127.88 | 225.626 | 36.834 | 6.116 | -15.131 | 29.914 |
Cash At End Of Period
| 433.519 | 415.211 | 335.05 | 376.397 | 131.519 | 125.334 | 168.545 | 296.425 | 70.799 | 33.965 | 27.85 | 42.981 |